limited to

150

Attendees

limited to

120

Companies

30

Speakers

Testimonials

"I was enjoying the conference a lot. This one was one of the most professional conferences I have attended so far because it gathers the best international specialists in this field."

Hanna Hlushchenko, Business Development Director, Cannextra/Cannexpor Pharma Europe

"Our VP Business Development was very impressed with the networking opportunities at the conference."

Debra Senger, Founder and CEO, PhyeinMed

"The conference was fantastic! There were lots of B2B relationships and I encourage anyone to attend."

Mark Lewis, President, Napro Research

How It Works

Through a mix of case-study presentations, interactive roundtable discussions, Q&A sessions and hands-on workshops you will gain a diverse and inspiring perspective. The multi stream format allows you to move freely between the conferences and choose the sessions of most interest and relevance. Create your program from the case studies and interactive round tables.

Move freely between the streams

Customize your program

Attend the sessions of most interest

Get Inspired by the Sessions You Choose from All Streams

Best Practices from Production to Distribution
Target Group

Leaders along the Medical Cannabis and Industrial Hemp value chain from industries such as growers, cultivators, dispensaries, retail, infused product manufacturers, pharma, healthcare and investors

Key Topics
  • Manufacturing best practices
  • Cultivation best practices
  • Best practices in the production process
  • New industry developments
  • CBD and THC innovations
Regulation and Business Strategy
Target Group

Leaders along the Medical Cannabis and Industrial Hemp value chain from industries such as growers, cultivators, dispensaries, retail, infused product manufacturers, pharma, healthcare and investors

Key Topics
  • Legalization in France
  • Business development
  • Market development
  • Marketing strategies
  • Mergers and acquisitions

Agenda

Filter by Track:

TUESDAY, JANUARY 26TH

9:00

Introduction of the Chairman

Sébastien Béguerie

CEO and Founder
Alpha‑CAT
France

This session is in English

Introduction of the Chairman

Sébastien Béguerie

CEO and Founder
Alpha‑CAT
France

This session is in English

Introduction of the Chairman

Miles Voigt

Chief Sales Officer
AE Grünkraft
Switzerland

This session is in English

Introduction of the Chairman

Miles Voigt

Chief Sales Officer
AE Grünkraft
Switzerland

This session is in English

9:15

Cannabis and CBD Regulations in Europe: A Focus on the EU and French Regulatory Landscape

  • Overview of EU regulations governing cannabis-derived and CBD-based products
  • Situations in specific EU countries and differences in legislation
  • Cannabis and CBD in France: What is the latest state of play?

Eveline Van Keymeulen

Head of the Life Sciences Regulatory Practice
Allen & Overy
France

This session is in English

9:45

Aurélien Delecroix

President
Syndicat Professionnel du Chanvre
France

Political and Legal Issues of Hemp Wellness in France

  • The current French legal and political context
  • The economic significance of the industry in France
  • The challenges and potential ahead
This session is in English
Ludovic Rachou

Treasurer
Syndicat Professionnel du Chanvre
France

10:15

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

No Speaker Yet

If you'd like to be a speaker at this event, this slot is available.

10:45

Coffee Break with Networking

11:15

When Biotech Disrupts Cannabis Issues

  • Issues with classic indoors, field, greenhouse production
  • Presentation of three alternative biotech production methods
  • Comparison of the three methods
  • Conclusion: history and trends

Franck Pradier

Managing Director
Alkion BioInnovations
France

This session is in English

When Biotech Disrupts Cannabis Issues

  • Issues with classic indoors, field, greenhouse production
  • Presentation of three alternative biotech production methods
  • Comparison of the three methods
  • Conclusion: history and trends

Franck Pradier

Managing Director
Alkion BioInnovations
France

This session is in English

Is the European Union Learning from the Canadian and US Experience of the Cannabis & Hemp Market?

  • Learning about the impact of EU legislation on the French market
  • How can French cannabis & hemp regulations comply with EU law?
  • A brief comparison of European and North American cannabis & hemp markets
  • Challenges and barriers faced by Canada and the US in legalising cannabis: How to overcome them in Europe? 

Patrycja Bartosz-Burdiak

CEO and Co‑Founder
Orbis Cannabis
Poland

This session is in English

Is the European Union Learning from the Canadian and US Experience of the Cannabis & Hemp Market?

  • Learning about the impact of EU legislation on the French market
  • How can French cannabis & hemp regulations comply with EU law?
  • A brief comparison of European and North American cannabis & hemp markets
  • Challenges and barriers faced by Canada and the US in legalising cannabis: How to overcome them in Europe? 

Patrycja Bartosz-Burdiak

CEO and Co‑Founder
Orbis Cannabis
Poland

This session is in English

11:45

Learning from Germany's Medical Cannabis Approach

  • Best-practices of German medical cannabis regulation since March 2017
  • Role of medical cannabis product segments (flowers, full-spectrum extracts, isolates and finished products)
  • Pros and Cons of Germany's medical cannabis approach for other EU countries

Johann Benedikt Sons

CEO and Co‑Founder
Cansativa
Germany

This session is in English

Learning from Germany's Medical Cannabis Approach

  • Best-practices of German medical cannabis regulation since March 2017
  • Role of medical cannabis product segments (flowers, full-spectrum extracts, isolates and finished products)
  • Pros and Cons of Germany's medical cannabis approach for other EU countries

Johann Benedikt Sons

CEO and Co‑Founder
Cansativa
Germany

This session is in English

Would Cannabis Status Changes Within the International Scheduling Help and Facilitate Scientific Research and the Development of the Market for Medicinal Purposes?

  • Further delay on WHO's recommendations on cannabis-based products: What does this mean for the industry?
  • Future changes in the scope
  • Beyond the substances scheduling

Farid Ghehioueche

Head of Advocacy
FAAAT think & do tank
France

This session is in English

Would Cannabis Status Changes Within the International Scheduling Help and Facilitate Scientific Research and the Development of the Market for Medicinal Purposes?

  • Further delay on WHO's recommendations on cannabis-based products: What does this mean for the industry?
  • Future changes in the scope
  • Beyond the substances scheduling

Farid Ghehioueche

Head of Advocacy
FAAAT think & do tank
France

This session is in English

12:15

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Political and Legal Issues of Hemp Wellness in France - Aurélien Delecroix, President, Syndicat Professionnel du Chanvre and Ludovic Rachou, Treasurer, Syndicat Professionnel du Chanvre


When Biotech Disrupts Cannabis Issues - Franck Pradier, Managing Director, Alkion BioInnovations


Learning from Germany's Medical Cannabis Approach - Johann Benedikt Sons, CEO and Co‑Founder, Cansativa

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Political and Legal Issues of Hemp Wellness in France - Aurélien Delecroix, President, Syndicat Professionnel du Chanvre and Ludovic Rachou, Treasurer, Syndicat Professionnel du Chanvre


When Biotech Disrupts Cannabis Issues - Franck Pradier, Managing Director, Alkion BioInnovations


Learning from Germany's Medical Cannabis Approach - Johann Benedikt Sons, CEO and Co‑Founder, Cansativa

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Cannabis and CBD Regulations in Europe: A Focus on the EU and French Regulatory Landscape - Eveline Van Keymeulen, Head of the Life Sciences Regulatory Practice, Allen & Overy


Is the European Union Learning from the Canadian and US Experience of the Cannabis & Hemp Market? - Patrycja Bartosz-Burdiak, CEO and Co‑Founder, Orbis Cannabis


Would Cannabis Status Changes Within the International Scheduling Help and Facilitate Scientific Research and the Development of the Market for Medicinal Purposes? - Farid Ghehioueche, Head of Advocacy, FAAAT think & do tank

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Cannabis and CBD Regulations in Europe: A Focus on the EU and French Regulatory Landscape - Eveline Van Keymeulen, Head of the Life Sciences Regulatory Practice, Allen & Overy


Is the European Union Learning from the Canadian and US Experience of the Cannabis & Hemp Market? - Patrycja Bartosz-Burdiak, CEO and Co‑Founder, Orbis Cannabis


Would Cannabis Status Changes Within the International Scheduling Help and Facilitate Scientific Research and the Development of the Market for Medicinal Purposes? - Farid Ghehioueche, Head of Advocacy, FAAAT think & do tank

13:00

Lunch with Networking

14:30

Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France

  • Fundraising in France for hemp and cannabis, between stigma and poor knowledge
  • Is the Cannabis industry harsher than other industries?
  • Canadian cannabis companies and their impact on investments
  • 2020 and 2021, what will happen?

Franck Milone Delacourt

Founder and CEO
DelleD
France

This session is in English

Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France

  • Fundraising in France for hemp and cannabis, between stigma and poor knowledge
  • Is the Cannabis industry harsher than other industries?
  • Canadian cannabis companies and their impact on investments
  • 2020 and 2021, what will happen?

Franck Milone Delacourt

Founder and CEO
DelleD
France

This session is in English

France Experiences Cannabis: Aims and Facts, Hopes and Limitations

  • Ongoing experiment on medical cannabis in France
  • Medical, pharmaceutical and legal basis of the experiment
  • What is (not) expected to come out from this experiment?
  • What will be the next step?
  • Connections between cannabis and hemp sectors

Alexandre Maciuk

Associate Professor
BioCIS, University Paris Sud
Member of France's Temporary Scientific Committee (CST) For Medical Cannabis
France

This session is in English

France Experiences Cannabis: Aims and Facts, Hopes and Limitations

  • Ongoing experiment on medical cannabis in France
  • Medical, pharmaceutical and legal basis of the experiment
  • What is (not) expected to come out from this experiment?
  • What will be the next step?
  • Connections between cannabis and hemp sectors

Alexandre Maciuk

Associate Professor
BioCIS, University Paris Sud
Member of France's Temporary Scientific Committee (CST) For Medical Cannabis
France

This session is in English

15:00

Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role?

  • Talk about the fund we are launching and why we are launching it in Europe and are based in France
  • Overview of EU ecosystem and what kind of new companies are being created in the space and how France is catching up (fast)
  • Overview of why Europe is the "place to be" for medical cannabis and how France can be a part of it
  • Overview of research and development done in cannabinoids as well as the startups that are commercializing products in France
  • Advantages of France vs other geographies for developping tech

Alexandre Ouimet-Storrs

Co‑Founder and Managing Director
Oskare Capital
France

This session is in English

Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role?

  • Talk about the fund we are launching and why we are launching it in Europe and are based in France
  • Overview of EU ecosystem and what kind of new companies are being created in the space and how France is catching up (fast)
  • Overview of why Europe is the "place to be" for medical cannabis and how France can be a part of it
  • Overview of research and development done in cannabinoids as well as the startups that are commercializing products in France
  • Advantages of France vs other geographies for developping tech

Alexandre Ouimet-Storrs

Co‑Founder and Managing Director
Oskare Capital
France

This session is in English

Cosmetics and Beauty Market: CBD is the New Black!

  • What does the regulation state?
  • The boom of the CBD and hemp cosmetics market in the past few years
  • Formulation, registration, production and laboratory testing
  • Strategies to market CBD-based cosmetics

Joanna Weaver-Pélissier

CEO
Be Cann
France

This session is in English

Cosmetics and Beauty Market: CBD is the New Black!

  • What does the regulation state?
  • The boom of the CBD and hemp cosmetics market in the past few years
  • Formulation, registration, production and laboratory testing
  • Strategies to market CBD-based cosmetics

Joanna Weaver-Pélissier

CEO
Be Cann
France

This session is in English

15:30

Coffee Break with Networking

16:00

Regulation and Quality Control in CBD Industry

  • Inside Europe's booming CBD market, which CBD brands to trust and how to make sure of the CBD quality?
  • CBD isolate or CBD broad spectrum or CBD full spectrum: how can a consumer know if he is really getting what he is buying?
  • Certificate of analysis and labelling guidelines are key to ensure CBD product quality

Sébastien Béguerie

CEO and Founder
Alpha‑CAT
France

This session is in English

Regulation and Quality Control in CBD Industry

  • Inside Europe's booming CBD market, which CBD brands to trust and how to make sure of the CBD quality?
  • CBD isolate or CBD broad spectrum or CBD full spectrum: how can a consumer know if he is really getting what he is buying?
  • Certificate of analysis and labelling guidelines are key to ensure CBD product quality

Sébastien Béguerie

CEO and Founder
Alpha‑CAT
France

This session is in English

A Bright Future for Legalization: What France Can Learn from Luxembourg and Belgium

  • Why Luxembourg has a headstart over the rest of the EU
  • Possible changes to come from the recent development in Luxembourg
  • Tobaccolicensing of CBD products as seen in Luxembourg and Belgium

Miles Voigt

Chief Sales Officer
AE Grünkraft
Switzerland

This session is in English

A Bright Future for Legalization: What France Can Learn from Luxembourg and Belgium

  • Why Luxembourg has a headstart over the rest of the EU
  • Possible changes to come from the recent development in Luxembourg
  • Tobaccolicensing of CBD products as seen in Luxembourg and Belgium

Miles Voigt

Chief Sales Officer
AE Grünkraft
Switzerland

This session is in English

16:30

Engineering Cannabis of the Future: What to Expect

  • Breeding new cannabis varieties: what are the challenges?
  • New Breeding Techniques & Genetic Engineering: how can they help?
  • How far are we from the future?

Ying Shao

Co‑Founder and CEO
Plantik Biosciences
France

This session is in English

Engineering Cannabis of the Future: What to Expect

  • Breeding new cannabis varieties: what are the challenges?
  • New Breeding Techniques & Genetic Engineering: how can they help?
  • How far are we from the future?

Ying Shao

Co‑Founder and CEO
Plantik Biosciences
France

This session is in English

CBD Business in France: How to Navigate the Complex Regulatory Landscape

  • Legislation and regulatory challenges faced by French CBD players
  • What you need to know to be compliant
  • What are the common mistakes to avoid

Marie Sanchez

Founder and Lawyer
NOOA Avocats
France

This session is in English

CBD Business in France: How to Navigate the Complex Regulatory Landscape

  • Legislation and regulatory challenges faced by French CBD players
  • What you need to know to be compliant
  • What are the common mistakes to avoid

Marie Sanchez

Founder and Lawyer
NOOA Avocats
France

This session is in English

17:00

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France - Franck Milone Delacourt, Founder and CEO, DelleD


Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role? - Alexandre Ouimet-Storrs, Co‑Founder and Managing Director, Oskare Capital


Regulation and Quality Control in CBD Industry - Sébastien Béguerie, CEO and Founder, Alpha‑CAT


Engineering Cannabis of the Future: What to Expect - Ying Shao, Co‑Founder and CEO, Plantik Biosciences

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Why Raising Capital is a Challenge for Cannabis and Hemp Startups in France - Franck Milone Delacourt, Founder and CEO, DelleD


Europe's Evolving Medical Cannabis Ecosystem: How Can France Play a Role? - Alexandre Ouimet-Storrs, Co‑Founder and Managing Director, Oskare Capital


Regulation and Quality Control in CBD Industry - Sébastien Béguerie, CEO and Founder, Alpha‑CAT


Engineering Cannabis of the Future: What to Expect - Ying Shao, Co‑Founder and CEO, Plantik Biosciences

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

France Experiences Cannabis: Aims and Facts, Hopes and Limitations - Alexandre Maciuk, Associate Professor, BioCIS, University Paris Sud


A Bright Future for Legalization: What France Can Learn from Luxembourg and Belgium - Miles Voigt, Chief Sales Officer, AE Grünkraft


CBD Business in France: How to Navigate the Complex Regulatory Landscape - Marie Sanchez, Founder and Lawyer, NOOA Avocats

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

France Experiences Cannabis: Aims and Facts, Hopes and Limitations - Alexandre Maciuk, Associate Professor, BioCIS, University Paris Sud


A Bright Future for Legalization: What France Can Learn from Luxembourg and Belgium - Miles Voigt, Chief Sales Officer, AE Grünkraft


CBD Business in France: How to Navigate the Complex Regulatory Landscape - Marie Sanchez, Founder and Lawyer, NOOA Avocats

17:45

Panelists

Sentob Toledano ‑ La Hemperie
Karolina Willoqueaux ‑ Biokonopia
Quitterie de Rivoyre ‑ WholyMe

Panel Discussion: Innovations in the Cannabis Industry - What Makes France Stand Out?

  • Innovative technologies in medical cannabis & CBD wellness
  • Spotlight on French excellence in the field of cannabis production and transformation
  • The potential of France in being the EU member state that unlocks the European medicinal cannabis & CBD market
This session is in English
Benjamin-Alexandre Jeanroy

CEO
Augur Associates
France

18:45

Summary of the First Day of the Conference

19:00

Evening Reception

Engage in exciting conversations. Strengthen your network after a day full of knowledge sharing, groundbreaking presentations, and interesting conversations. Join delegates and speakers in the relaxed atmosphere of the event venue.

This session is in English

WEDNESDAY, JANUARY 27TH

9:00

Introduction by World Class Business Leaders

9:15

Benjamin-Alexandre Jeanroy

CEO
Augur Associates
France

Panel Discussion: Medical Use of Cannabis in France - Where do we Stand Today?

  • The institutional processes for the implementation of medical cannabis in France
  • The role and responsibilities of each key player (healthcare professionals, industry, entrepreneur, patient organisation...)
  • Current trends and future perspectives
This session is in English
Panelists

Pascal Douek ‑ Elmo
Franck Milone ‑ DelleD
Hélène Moore ‑ Aurora

10:15

Unlocking the French Medical Cannabis Market: A Concerted Effort

  • Unlocking the French Medical Cannabis Market: A concerted effort
  • The French cannabis market: Where are we now?
  • Opportunities and challenges faced by the cannabis industry players in France
  • Medical cannabis education: How France is creating a blueprint for Europe

Hélène Moore

Managing Director
Aurora
France

This session is in English

10:45

Smokable Hemp in Europe: Legal Framework and Future Perspective

  • Presentation of hemp tobacco subsidiaries in Switzerland and Europe
  • A comparative analysis of the legal framework in Europe
  • The state of the smokable hemp market in France
  • Opportunities for French/European hemp producers

Karolina Willoqueaux

Vice President
Biokonopia
Switzerland

This session is in English

11:15

Coffee Break with Networking

11:45

Medical Cannabis in France: The Green Light to a Two-Year Experiment

  • Understanding the internal context that led France to launch a medical cannabis experiment
  • Review of the legal and procedural framework for the experiment
  • Action items and next steps for the ANSM's Temporary Scientific Committee

Pascal Douek

Medical Doctor, Blogger and Author
Member of France's Temporary Specialized Scientific Committee (CSST) For Medical Cannabis from 2018 to 2019
France

This session is in English

12:15

European Companies: How to Ride the Cannabis Wave on the Continent?

  • Medical cannabis vs CBD for wellness
  • Situations, scenario and strategic positioning
  • Lessons from the field in Paris, London and Brussels

Laurène Tran

Executive Director
ACTIVE
France

This session is in English

12:45

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Unlocking the French Medical Cannabis Market: A Concerted Effort - Hélène Moore, Managing Director, Aurora


Smokable Hemp in Europe: Legal Framework and Future Perspective - Karolina Willoqueaux, Vice President, Biokonopia


Medical Cannabis in France: The Green Light to a Two-Year Experiment - Pascal Douek, Medical Doctor, Blogger and Author, Member of France's Temporary Specialized Scientific Committee (CSST) For Medical Cannabis from 2018 to 2019


European Companies: How to Ride the Cannabis Wave on the Continent? - Laurène Tran, Executive Director, ACTIVE

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Unlocking the French Medical Cannabis Market: A Concerted Effort - Hélène Moore, Managing Director, Aurora


Smokable Hemp in Europe: Legal Framework and Future Perspective - Karolina Willoqueaux, Vice President, Biokonopia


Medical Cannabis in France: The Green Light to a Two-Year Experiment - Pascal Douek, Medical Doctor, Blogger and Author, Member of France's Temporary Specialized Scientific Committee (CSST) For Medical Cannabis from 2018 to 2019


European Companies: How to Ride the Cannabis Wave on the Continent? - Laurène Tran, Executive Director, ACTIVE

13:30

Lunch with Networking

15:00

Pavel Kubu

CEO
International Cannabis and Cannabinoids Institute (ICCI)
Czech Republic

Navigating the International Drug Control Landscape for Cannabis

  • International drug control treaties and cannabis
  • Flexibility in the interpretation of treaty provisions
  • Challenges for patients, researchers and industry
This session is in English
Pavel Pachta

Director for International Regulatory Affairs
International Cannabis and Cannabinoids Institute (ICCI)
Czech Republic

15:30

Medicinal Cannabis in Luxembourg: Regulatory Challenges in the Heart of Europe

  • What are the current political personnel and administrative bodies in charge of medicinal cannabis in Luxembourg?
  • An overview of the current regulatory framework in the Grand Duchy
  • What is the Consumer Choice Center's perspective on the risk of over-promising of health benefits, and how exaggerated CBD product claims can threaten medicinal legalisation efforts
  • How Luxembourg could open the way forward for better international trade with medical cannabis, particularly in the single market

Bill Wirtz

Senior Policy Analyst
Consumer Choice Center
Belgium

This session is in English

16:00

What France can Learn from The Danish Medical Cannabis Pilot Program

  • What drove The Minister of Health to support the medical cannabis scheme in Denmark?
  • An overview of the legal framework in Denmark
  • Barriers and challenges encountered in implementing the pilot program
  • An update on the program's progress and the next steps

Rikke Jakobsen

CEO
Cannabis Danmark
Denmark

This session is in English

16:30

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Navigating the International Drug Control Landscape for Cannabis - Pavel Kubu, Chief Executive Officer, International Cannabis and Cannabinoids Institute (ICCI) and Pavel Pachta, Director for International Regulatory Affairs, International Cannabis and Cannabinoids Institute (ICCI)


Medicinal Cannabis in Luxembourg : Regulatory Challenges in the Heart of Europe - Bill Wirtz, Senior Policy Analyst, Consumer Choice Center


What France can Learn from The Danish Medical Cannabis Pilot Program - Rikke Jakobsen, CEO, Cannabis Danmark

Round-Table Discussions

Engage with the speakers in extended Q&A sessions to dive deeper into the topics:

Navigating the International Drug Control Landscape for Cannabis - Pavel Kubu, Chief Executive Officer, International Cannabis and Cannabinoids Institute (ICCI) and Pavel Pachta, Director for International Regulatory Affairs, International Cannabis and Cannabinoids Institute (ICCI)


Medicinal Cannabis in Luxembourg : Regulatory Challenges in the Heart of Europe - Bill Wirtz, Senior Policy Analyst, Consumer Choice Center


What France can Learn from The Danish Medical Cannabis Pilot Program - Rikke Jakobsen, CEO, Cannabis Danmark

17:15

End of the Conference with Summary

Book Your Tickets

Conference Pass

The ticket includes full access to the Expo and all sessions in all streams, including the evening reception on the first day. This also includes 12 months of full access to all the online features (matched networking and collaboration in the event online think tank, presentations, and the video archive of all World Class Business Leaders conferences). Catering at the event is included. Choose your pass and click on “Book Conference Pass” to access the registration form.

Cultivators, producers, distributors and retailers must book this pass to attend the conference.

View pass description

Consultants, ancillary businesses, solution and service providers, and investors must book this pass to attend the conference.

View pass description

Employees of public institutions such as government, military and universities can take advantage of this special price.

Book Conference Pass

World Class Unlimited Online Pass

Access the presentations from this conference online as well as hundreds of other case study videos from global business leaders. The videos are full-length and include the PDFs of the presentation. More videos are added each month with new World Class Business Leaders business transformation conferences bringing best practices to you from around the world. Don't lose this opportunity to stay on top of what business leaders currently do and plan for the future to gain a competitive edge. 12 months of World Class Unlimited are included in any of the Conference Passes.

Book World Class Unlimited Online Pass

Travel & Accommodation

Hotel Novotel Roissy CDG Convention & Spa
10 Allée du Verger, 95700 Roissy-en-France, France

For deliveries, please add to the address the following:
26th + 27th January & WCBLeaders

ACCESS AND TRANSPORT

Located a stone's throw from Paris Roissy CDG Airport, the conference location boasts a central location that offers easy access.

From Paris:
Highway A1 in the direction of Lille exit n°6
Follow Roissy en France / Senlis, then Roissy en France, Allée des Vergers

From Lille / Brussels:
Highway A1 in the direction of Paris exit n°6
Follow the direction of Roissy-en-France and then Roissy-en-France, Senlis At the roundabout, go forward, entrance of Roissy en France
Take the first right, Allée du Verger.

Outdoor and indoor parking (paying)

From R.E.R station at Roissypôle:
Go outside of the RER station, « Shuttles and taxis » side Take the shuttle (Black bus) for Roissy ville

From RER line B from Paris:
Leave at the station Roissy CDG1-3, and then go outside at « shuttles and taxis » area Take the shuttle (Black bus) for Roissy ville

From the Charles De Gaulle 2 TGV station:
Follow the indications for hotel shuttles

The shuttle stops:
From terminal 1, take the automatic shuttle rail service « CDG Val » to Roissypôle. The CDG VAL is every 4 minutes, 24hours a day
From terminal 2, follow the direction to TGV station (between terminals 2D and 2F), Go up to level 5.
From terminal 3, go by walk to the shuttle stop located in front of Roissypôle and RER station.

Book your hotel room here:
https://www.accorhotels.com/fr/hotel-5418-novotel-roissy-cdg-convention-spa/index.shtml
or call: (+33)1/30182000

Supported by Partners such as

Think Tank

As a registered attendee, visit the event’s online think tank where you can see your fellow attendees’ profiles and priorities to get in touch, arrange meetings and collaborate with your best networking opportunities. Also, your conference documentation awaits you in this World Class Business Leaders think tank.

Visit the Think Tank

Contributors

Become a Speaker or Sponsor

We are looking for the best practices that shape tomorrow's world. If you would like to contribute to this event as speaker, please fill out the speaker application form here.

Speaker Application

If you have already been in contact with the event organization team and are confirming the details of your presentation, please access the speaker questionnaire here.

Register as a Speaker

Get in front of top decision makers of your field! In total, we expect more than € 100M in budgets attending. To get more information and make your business grow, inquire here.

Become a Sponsor

Downloads

Download additional materials about the conference. You will find flyers, logos, banners, signature templates as well as press releases.

Download Conference Materials

Matchmaking-powered Event Experience and Unique Networking Service

100% embedded into the World Class Business platform.

See who you definitely need to network with.

Manage your networking meetings.

Best practices and experts remain only a click away after the event.

...